Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MATTHEWS W GWYNN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1225112667
CMS profile
236634
Location
ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$3,423.50

165 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,423.50 165

By paying entity

PY2024 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 165 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MATTHEWS W GWYNN

NPI 1225112667 · CMS profile ID 236634

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 165 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1225112667?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MATTHEWS W GWYNN, NPI 1225112667, CMS profile ID 236634. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 165 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1225112667?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). MATTHEWS W GWYNN, NPI 1225112667, CMS profile ID 236634. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 165 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1225112667?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
MATTHEWS W GWYNN, NPI 1225112667, CMS profile ID 236634, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 165 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1225112667?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

165 matching records · $3,423.50 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 165 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 165.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $8.0504/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857539 CMS
ABBVIE INC. $28.2204/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857537 CMS
Lundbeck LLC $29.3504/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145921940 CMS
ABBVIE INC. $25.9404/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857535 CMS
Boston Scientific Corporation $31.6304/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092395544 CMS
PFIZER INC. $20.8904/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131257172 CMS
ABBVIE INC. $8.1404/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857533 CMS
ABBVIE INC. $10.1704/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857531 CMS
ARGENX US, INC. $24.9104/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142105207 CMS
Merz Pharmaceuticals, LLC $21.2404/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137952252 CMS
Amneal Pharmaceuticals LLC $13.5604/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139187962 CMS
SK Life Science, Inc. $22.8503/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154148418 CMS
ABBVIE INC. $4.8103/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857529 CMS
Eisai Inc. $15.2603/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110764713 CMS
ABBVIE INC. $31.1603/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857527 CMS
Lundbeck LLC $19.8603/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145921938 CMS
ABBVIE INC. $18.6103/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857523 CMS
ABBVIE INC. $33.3303/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857525 CMS
Sumitomo Pharma America, Inc. $26.0603/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148860149 CMS
PFIZER INC. $23.1603/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131190548 CMS
ABBVIE INC. $20.2803/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857521 CMS
Biogen, Inc. $22.7803/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104868174 CMS
ABBVIE INC. $17.0303/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857519 CMS
ABBVIE INC. $12.0203/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857517 CMS
Currax Pharmaceuticals LLC $13.6303/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089513310 CMS
UCB, Inc. $21.0703/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143170402 CMS
ABBVIE INC. $29.3703/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857513 CMS
ABBVIE INC. $5.4203/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857515 CMS
MITSUBISHI TANABE PHARMA AMERICA, INC. $22.4503/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144507852 CMS
Teva Pharmaceuticals USA, Inc. $17.3903/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151635324 CMS
ABBVIE INC. $13.4402/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857511 CMS
PFIZER INC. $18.4002/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131156691 CMS
Merz Pharmaceuticals, LLC $21.0602/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137952250 CMS
Neurelis, Inc. $27.9502/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145642866 CMS
ABBVIE INC. $19.1602/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857509 CMS
Neurocrine Biosciences, Inc. $25.1702/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150839360 CMS
UCB, Inc. $22.9802/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143170400 CMS
Lilly USA, LLC $18.2802/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135185513 CMS
Biogen, Inc. $19.9202/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104878616 CMS
ABBVIE INC. $7.2502/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857507 CMS
Sumitomo Pharma America, Inc. $28.7302/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148860147 CMS
ABBVIE INC. $22.1802/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857505 CMS
Lundbeck LLC $27.9702/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145921936 CMS
Eisai Inc. $116.0101/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110764705 CMS
ABBVIE INC. $19.4601/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857503 CMS
UCB, Inc. $25.2801/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143170398 CMS
ABBVIE INC. $20.3301/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857501 CMS
ABBVIE INC. $4.3101/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857499 CMS
ABBVIE INC. $14.3001/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103857497 CMS
PFIZER INC. $18.6601/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131156688 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,091.81 136
PY2020 $12,918.58 131
PY2021 $4,157.38 150
PY2022 $3,104.25 169
PY2023 $3,297.40 157
PY2024 $3,423.50 165
PY2025 $3,287.77 153

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $177,098.21 24
PY2024 Principal investigator $152,131.58 3
PY2022 Principal investigator $76,226.43 9
PY2021 Principal investigator $107,765.36 26
PY2020 Principal investigator $116,963.46 26
PY2019 Principal investigator $111,966.03 18

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

24 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $500.00 12/31/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH INC
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Ubrogepant for the Preventive Treatment of Menstrual Migraine with an Open-Label Extension No dispute reported 06/30/2026 1202534171
Principal investigator 1 H. Lundbeck A S $12,699.25 12/15/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251778586
Principal investigator 1 ABBVIE INC. $3,206.25 12/04/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202527630
Principal investigator 1 Ipsen Innovation $126.00 11/25/2025 Non-covered Recipient Entity
Neurotrials Research
A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose Escalation and Dose Finding Phase II Study to Evaluate the Safety and Efficacy of IPN10200 in the Prevention of Episodic or Chronic Migraine in Adults No dispute reported 06/30/2026 1184302813
Principal investigator 1 Ipsen Innovation $695.00 11/10/2025 Non-covered Recipient Entity
Neurotrials Research
A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose Escalation and Dose Finding Phase II Study to Evaluate the Safety and Efficacy of IPN10200 in the Prevention of Episodic or Chronic Migraine in Adults No dispute reported 06/30/2026 1184302809
Principal investigator 1 Ipsen Innovation $2,790.00 11/10/2025 Non-covered Recipient Entity
Neurotrials Research
A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose Escalation and Dose Finding Phase II Study to Evaluate the Safety and Efficacy of IPN10200 in the Prevention of Episodic or Chronic Migraine in Adults No dispute reported 06/30/2026 1184302811
Principal investigator 1 ABBVIE INC. $49.10 10/23/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202518271
Principal investigator 1 H. Lundbeck A S $4,000.00 10/06/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251775391
Principal investigator 1 H. Lundbeck A S $1,322.26 09/15/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251774765
Principal investigator 1 H. Lundbeck A S $1,050.00 09/15/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251774778
Principal investigator 1 H. Lundbeck A S $2,644.52 07/07/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251771862
Principal investigator 1 H. Lundbeck A S $15,008.00 07/07/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251771871
Principal investigator 1 ABBVIE INC. $13,500.00 07/02/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202494281
Principal investigator 1 H. Lundbeck A S $40,317.33 06/17/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251771165
Principal investigator 1 H. Lundbeck A S $810.00 06/17/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251771188
Principal investigator 1 H. Lundbeck A S $3,650.00 04/15/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251769719
Principal investigator 1 H. Lundbeck A S $18,336.88 04/10/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251769631
Principal investigator 1 H. Lundbeck A S $3,289.95 03/18/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251768833
Principal investigator 1 H. Lundbeck A S $21,895.82 03/10/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251768581
Principal investigator 1 H. Lundbeck A S $13,338.01 03/03/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251767975
Principal investigator 1 H. Lundbeck A S $3,586.95 03/03/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251767997
Principal investigator 1 H. Lundbeck A S $7,210.32 02/04/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH INC
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251766900
Principal investigator 1 H. Lundbeck A S $4,850.00 02/04/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH INC
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251766908
Principal investigator 1 H. Lundbeck A S $2,222.57 01/06/2025 Non-covered Recipient Entity
NEUROTRIALS RESEARCH INC
A TRIAL INVESTIGATING LU AG09222 WITH UBROGEPANT IN PARTICIPANTS WITH MIGRAINE No dispute reported 06/30/2026 1251766158